Oxygen Therapy Market Size, Share & Trends Analysis Report By Product (Oxygen Source Equipment, Oxygen Delivery Devices, Static, Dynamic), By Application, By End-use, And Segment Forecasts, 2018 - 2024

1. FollowUs:
Oxygen Therapy Market Scope, Industry Demand Analysis And
Forecast To 2024| Grand View Research, Inc
The global oxygen therapy market is expectedto reach USD 18.2 billionby 2024, according to a new study by Grand
ViewResearch, Inc. The increasing prevalence of major respiratory diseases,such as Chronic Obstructive Pulmonary
Disease (COPD), asthma, and obstructive sleepapnea, is a high impact renderingdriver of oxygentherapy market.
As per the estimates of the WHO, a consequential global rise in the prevalence of asthma and other respiratory
disorders, is expectedto heightenedclinical urgency to treat the aforementioneddisorders and is expectedto boost
the demand for oxygen therapy as the first line treatment and as a supplementin various applications.
Moreover, technological advancements are anticipated to provide growth platforms in a wide range of new
applications such as cancer and diabetes;for instance, incorporation of flow sensors in deliverydevicesto conserve
and regulate the flow enablinggreater patientcomfort and outcomes.
Furthermore, the increasing focus on home healthcare solutionscoupled with the developmentof portable delivery
deviceshas a major impact on the oxygen therapy market. These aforementionedfactors are expectedto serve as
key contributing factors towards the growth of the oxygentherapy market over the forecast period.
Browse Details of Report @ www.grandviewresearch.com/industry-analysis/oxygen-therapy-market
“The global oxygen therapy market size was estimated at USD 7.09 billion in
2015 and is anticipated to growat a CAGR of 11.1% over the forecast period.”

2. FollowUs:
Further key findings from the study suggest:
 The oxygen source equipmentsegmentdominated the product segment in terms of revenue share in
2015owing toits high usage rate and wide scale availabilityin various forms such as liquidcompressed gas,
and concentrators. On the other hand, oxygendeliverydevicesare expectedto grow at a lucrative rate being
an indispensable part of the oxygentherapy set-ups,therebycontributing towards the overall oxygentherapy
market growth during the forecast period.
 Oxygenconcentrator spear headed the source equipmentmarket segmentowing to rising popularity and
adoption of Portable Concentrators in emergency medicine,ambulatory, and home settings.
 Oxygenmasks dominateddeliverydevice market segmentat over USD 800.0 millionin 2015, as a
consequence of being the indispensable unitof the deliverysystemand greater availabilityof specialty masks
as per the patient’s physiological needs
 Chronic Obstructive Pulmonary Disease (COPD) helda substantial market share of application segmentand
constituted for over 37.0%of the overall revenue share, owing to presence of unmet needspertinentto COPD
treatment, thereby propellingthe demandfor oxygentherapy market
 Home Healthcare is anticipated to grow lucrativelyat CAGR of 11.8% owing to associated benefits such as
long-term cost efficiencyand increasedmobility,propellingthe demand over the forecast period.Moreover,
presence of organizations such American Associationfor Homecare to promote awareness and strengthen
home healthcare are expectedto provide growth platform in future to oxygentherapy market
 The key players in this industry include CareFusion, Corp., Tecno-Gaz Industries, GE Healthcare, Hersill,
DeVilbissHealthcare, PhilipsRespironics,Inc., MAQUET Medical Systems, AlliedHealthcare Products, Smiths
Medical, Fisher & Paykel Healthcare Limited,Invacare Corporation and Teleflex Incorporated
 These industry players are adopting strategies such as new product development,technological innovation,
and strategic collaborations, such as mergers &acquisitions,to capitalize theirindustry share. For instance, in
May 2015, Fisher & Paykel Healthcare launchedAIRVO nasal high-flow systemto expandits product portfolio
and capture greater share of oxygentherapy market.
Grand ViewResearch has segmentedthe oxygen therapy market on the basis of product, application, end-use,and
region:
Global Oxygen Therapy Product Outlook (Revenue,USD Million, 2012 - 2022)
 OxygenSource Equipment
o OxygenCylinders
o OxygenConcentrators
o Liquid OxygenDevices
o PAP Devices
 OxygenDeliveryDevice
o OxygenMasks
o Nasal Cannula
o Venturi Masks

3. FollowUs:
o Non-rebreatherMasks
o Bag Valve Masks
o CPAP Masks
o Others
Global Oxygen Therapy Application Outlook (Revenue, USD Million, 2014 - 2024)
 Chronic Obstructive Pulmonary Disease
 Asthma
 Obstructive SleepApnea
 Respiratory Distress Syndrome
 Cystic Fibrosis
 Pneumonia
 Others
Global Oxygen Therapy End-Use Outlook (Revenue, USD Million,2014 - 2024)
 Home Healthcare
 Hospital
Oxygen Therapy Regional Outlook (Revenue, USD Million, 2014 - 2024)
 North America
o U.S.
o Canada
 Europe
o UK
o Germany
 Asia Pacific
o Japan
o China
o India
 Latin America
o Mexico
o Brazil
 MEA
o South Africa
Browse Related Category Reports @ www.grandviewresearch.com/industry/medical-devices

4. FollowUs:
Table of Content of Oxygen Therapy Market
Chapter 1 MethodologyandScope
1.1 Countrywise marketcalculation
1.2 Regionbasedsegmentshare calculation
1.3 PrimarySources
1.4 Listof secondarysources
Chapter 2 Executive Summary
Chapter 3 OxygenTherapy Industry Outlook
3.1 Market segmentation
3.2 Market size andgrowthprospects,2014 - 2024
3.3 Oxygentherapy:Marketdynamics
3.3.1 Market driveranalysis
3.3.1.1 Risingincidencesof respiratorydiseases
3.3.1.2 Technological advancements
3.3.2 Market restraintanalysis
3.3.2.1 Complex regulatoryframework
3.4 KeyOpportunityPrioritized
3.4.1 KeyOpportunityPrioritizedbyend-use
3.5 OxygentherapyCompetitive Landscape,2015
3.5.1 CompanyMarket Share Analysis,2015
3.5.2 CompetitiveLandscape:MarketPositionAnalysis
3.6 Industryanalysis - Porter’s
3.7 Oxygentherapy - PESTEL analysis
Chapter 4 OxygenTherapy Product Outlook
4.1 Oxygentherapymarketshare,byproduct,2015 & 2024
4.2 OxygenSource Equipment
4.2.1 Oxygensource equipmentmarket,2014 - 2024 (USD Million)
4.2.2 OxygenCylinders
4.2.2.1 Oxygencylindersmarket,2014 - 2024 (USD Million)
4.2.3 OxygenConcentrators
4.2.3.1 Oxygenconcentratorsmarket,2014 - 2024 (USD Million)
4.2.4 LiquidOxygenDevices

5. FollowUs:
4.2.4.1 Liquidoxygendevicesmarket,2014 - 2024 (USD Million)
4.2.5 PAPDevices
4.2.5.1 PAPdevicesmarket,2014 - 2024 (USD Million)
4.3 OxygenDeliveryDevices
4.3.1 Oxygendeliverydevicesmarket,2014 - 2024 (USD Million)
4.3.2 OxygenMasks
4.3.2.1 Oxygenmasksmarket,2014 - 2024 (USD Million)
4.3.3 Nasal Cannula
4.3.3.1 Nasal cannulamarket,2014 - 2024 (USDMillion)
4.3.4 Venturi Masks
4.3.4.1 Venturi masksmarket,2014 - 2024 (USD Million)
4.3.5 Non-rebreatherMasks
4.3.5.1 Non-rebreathermasksmarket,2014 - 2024 (USD Million)
4.3.6 Bag Valve Masks
4.3.6.1 Bag valve masksmarket,2014 - 2024 (USD Million)
4.3.7 CPAPMasks
4.3.7.1 CPAPmasksmarket,2014 - 2024 (USD Million)
4.3.8 Others
4.3.8.1 Othersmarket,2014 - 2024 (USD Million)
Chapter 5 OxygenTherapy ApplicationOutlook
5.1 Global Oxygentherapymarketshare,byapplication,2015 & 2024
5.2 ChronicObstructive PulmonaryDisease
5.2.1 Chronicobstructive pulmonarydisease market,2014 - 2024 (USD Million)
5.2.2 Asthma
5.2.2.1 Asthmamarket,2014 - 2024 (USD Million)
5.2.3 Obstructive SleepApnea
5.2.3.1 Obstructive sleepapneamarket,2014 - 2024 (USD Million)
5.2.4 RespiratoryDistressSyndrome
5.2.4.1 Respiratorydistresssyndrome market,2014 - 2024 (USD Million)
5.2.5 CysticFibrosis
5.2.5.1 Cysticfibrosismarket,2014 - 2024 (USD Million)
5.2.6 Pneumonia

6. FollowUs:
5.2.6.1 Pneumoniamarket,2014 - 2024 (USD Million)
5.2.7 Others
5.2.7.1 Othersmarket,2012 - 2022 (USD Million)
Chapter 6 OxygenTherapy End-use Outlook
6.1 Global oxygentherapymarketshare,byend-use,2015 & 2024
6.2 Home Healthcare
6.2.1 Home healthcare market,2014 - 2024 (USD Million)
6.3 Hospital
6.3.1 Hospital market,2014 - 2024 (USD Million)
Chapter 7 OxygenTherapy Regional Outlook
7.1 Oxygentherapymarketshare,byregion,2015 & 2024
7.2 NorthAmerica
7.2.1 North Americaoxygentherapymarket,2014 - 2024 (USD Million)
7.2.2 U.S.
7.2.2.1 U.S. oxygentherapymarket,2014 - 2024 (USD Million)
7.2.3 Canada
7.2.3.1 Canadaoxygentherapymarket,2014 - 2024 (USD Million)
7.3 Europe
7.3.1 Europe oxygentherapymarket,2014 - 2024 (USD Million)
7.3.2 UK
7.3.2.1 UK oxygentherapymarket,2014 - 2024 (USDMillion)
7.3.3 Germany
7.3.3.1 Germanyoxygentherapymarket,2014 - 2024 (USD Million)
7.4 AsiaPacific
7.4.1 AsiaPacificoxygentherapymarket,2014 - 2024 (USD Million)
7.4.2 Japan
7.4.2.1 Japanoxygentherapymarket,2014 - 2024 (USD Million)
7.4.3 China
7.4.3.1 Chinaoxygentherapymarket,2014 - 2024 (USD Million)
7.4.4 India
7.4.4.1 Indiaoxygentherapymarket,2014 - 2024 (USD Million)
7.5 LatinAmerica

7. FollowUs:
7.5.1 Latin Americaoxygentherapymarket,2014 - 2024 (USD Million)
7.5.2 Brazil
7.5.2.1 Brazil oxygentherapymarket,2014 - 2024 (USD Million)
7.5.3 Mexico
7.5.3.1 Mexicooxygentherapymarket,2014 - 2024 (USD Million)
7.6 MEA
7.6.1 MEA oxygentherapymarket,2014 - 2024 (USD Million)
7.6.2 South Africa
7.6.2.1 SouthAfricaoxygentherapymarket,2014 - 2024 (USD Million)
Chapter 8 Competitive Landscape
8.1 CareFusionCorporation
8.1.1 CompanyOverview
8.1.2 Financial Performance
8.1.3 Product Benchmarking
8.1.4 StrategicInitiatives
8.2 GE Healthcare
8.2.1 CompanyOverview
8.2.2 Financial Performance
8.2.3 Product Benchmarking
8.3 Tecno-GazIndustries
8.3.1 CompanyOverview
8.3.2 Financial Performance
8.3.3 Product Benchmarking
8.4 Hersill
8.4.1 CompanyOverview
8.4.2 Financial Performance
8.4.3 Product Benchmarking
8.5 PhilipsRespironics,Inc.
8.5.1 CompanyOverview
8.5.2 Financial Performance
8.5.3 Product Benchmarking
8.5.4 StrategicInitiatives

8. FollowUs:
8.6 DeVilbissHealthcare
8.6.1 CompanyOverview
8.6.2 Financial Performance
8.6.3 Product Benchmarking
8.6.4 StrategicInitiatives
8.7 MAQUET Medical Systems
8.7.1 CompanyOverview
8.7.2 Financial Performance
8.7.3 Product Benchmarking
8.7.4 StrategicInitiatives
8.8 SmithsMedical
8.8.1 CompanyOverview
8.8.2 Financial Performance
8.8.3 Product Benchmarking
8.8.4 StrategicInitiatives
8.9 AlliedHealthcare Products,Inc.
8.9.1 CompanyOverview
8.9.2 Financial Performance
8.9.3 Product Benchmarking
8.10 Fisher& Paykel Healthcare Limited
8.10.1 CompanyOverview
8.10.2 Financial Performance
8.10.3 ProductBenchmarking
8.10.4 StrategicInitiatives
8.11 TeleflexIncorporated
8.11.1 CompanyOverview
8.11.2 Financial Performance
8.11.3 ProductBenchmarking
8.11.4 StrategicInitiatives
8.12 Invacare Corporation
8.12.1 CompanyOverview
8.12.2 Financial Performance

9. FollowUs:
8.12.3 ProductBenchmarking
8.13 Chart Industries
8.13.1 CompanyOverview
8.13.2 Financial Performance
8.13.3 ProductBenchmarking
8.13.4 StrategicInitiatives
About Us:
Grand ViewResearch, Inc. is a U.S. based market research and consulting company, registered in the State of
California and headquartered in San Francisco. The company provides syndicated research reports, customized
research reports, and consulting services. To helpclients make informed business decisions, the company offers
market intelligence studiesensuring relevant and fact-based research across a range of industries including
technology, chemicals, materials, healthcare and energy.
Contact:
Sherry James
Corporate Sales Specialist,USA
Grand ViewResearch, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: http://www.grandviewresearch.com

10. FollowUs: